Placeholder canvas

COVID-19 | Health Ministry includes Remdesivir in ‘investigational therapy’ for restricted emergency use

Date:

Union Health Ministry on Sunday said that drug Remdesivir has been included as an ‘investigational therapy’ only for restricted emergency use on COVID-19 patients.

In a release, the Ministry of Health and Family Welfare intimated the updated Clinical Management Protocol for COVID-19, in which the drug Remdesivir has been included as an ‘investigational therapy’ only for restricted emergency use purposes along with off label use of Tocilizumab and Convalescent Plasma.

ALSO READ: COVID-19 testing to be increased in Delhi by three times in.. 

The said protocol also highlighted that the use of these therapies is based on limited available evidence and limited availability at present.

“Use of Remdesivir under emergency use may be considered in patients with moderate disease (those on oxygen) but with no specified contraindications. This drug has still not been approved (market authorization) by the US Food and Drug Administration (USFDA), where like India it continues only under an Emergency Use Authorization,” said the release.

However, there are certain conditions to be met, as per the release, for the restricted emergency usage of the drug.

“Written informed consent of each patient required, results of additional clinical trials to be submitted, active surveillance data of all treated patients to be submitted, risk management plan along with active post-marketing surveillance and reporting of serious adverse events also to be submitted. Additionally, the first three batches of imported consignments are to be tested and reports submitted to the Central Drug Standard Control Organisation (CDSCO),” added the release.

Health Ministry in the release said that Gilead, a biopharmaceutical company, had applied to the Indian Drug Regulatory Agency, namely CDSCO, for import and marketing of Remdesivir on May 29 and after due deliberations, permission under Emergency Use Authorization was granted on June 1 in the interest of patient safety and obtaining further data.

(With ANI inputs)

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Biden Administration Approves $60Million Aid For Baltimore Bridge Collapse

The Federal Administration in a statement on Thursday said that it has provided the quick-release funds to rebuild the collapsed bridge within hours of receiving a request from Maryland Department Of Transportation

Fact Check: Lok Sabha Polls Will Be Held Using EVMs; Don’t Fall For False Claim

Ahead of the Lok Sabha polls, a newspaper cutout...

Four Killed, Five Wounded In Stabbing Incident In North Illinois

Redd mentioned that not all of the victims had stab wounds and none of them were shot. She added by saying that they have a suspect in custody

Hope Everyone’s Rights Are Protected: UN On Kejriwal’s Arrest

Delhi CM Kejriwal was arrested by the ED(Enforcement Directorate) on March 21 in the Delhi liquor policy case, days ahead of the Lok Sabha polls